OBJECTIVES: Data on the impact and course of uncorrected tricuspid regurgitation (TR) during left ventricular assist device (LVAD) implantation are scarce and inconsistent. This study explores the clinical impact and natural course of uncorrected TR in patients after LVAD implantation. METHODS: The European Registry for Patients with Mechanical Circulatory Support was used to identify adult patients with LVAD implants without concomitant tricuspid valve surgery. A mediation model was developed to assess the association of TR with 30-day mortality via other risk factors. Generalized mixed models were used to model the course of post-LVAD TR. Joint models were used to perform sensitivity analyses. RESULTS: A total of 2496 procedures were included (median age: 56 years; men: 83%). TR was not directly associated with higher 30-day mortality, but mediation analyses suggested an indirect association via preoperative elevated right atrial pressure and creatinine (P = 0.035) and bilirubin (P = 0.027) levels. Post-LVAD TR was also associated with increased late mortality [hazard ratio 1.16 (1.06-1.3); P = 0.001]. On average, uncorrected TR diminished after LVAD implantation. The probability of having moderate-to-severe TR immediately after an implant in patients with none-to-mild TR pre-LVAD was 10%; in patients with moderate-to-severe TR pre-LVAD, it was 35% and continued to decrease in patients with moderate-to-severe TR pre-LVAD, regardless of pre-LVAD right ventricular failure or pulmonary hypertension. CONCLUSIONS: Uncorrected TR pre-LVAD and post-LVAD is associated with increased early and late mortality. Nevertheless, on average, TR diminishes progressively without intervention after an LVAD implant. Therefore, these data suggest that patient selection for concomitant tricuspid valve surgery should not be based solely on TR grade.

Department for Thoracic and Cardiovascular Surgery Heart and Diabetes Centre NRW Ruhr University Bochum Bad Oeynhausen Germany

Department of Cardiology Erasmus MC Rotterdam Netherlands

Department of Cardiology University Hospital Zurich University of Zurich Zurich Switzerland

Department of Cardiothoracic and Vascular Surgery German Heart Center Berlin Berlin Germany

Department of Cardiothoracic Surgery Erasmus MC Rotterdam Netherlands

Department of Cardiothoracic Surgery Institute for Clinical and Experimental Medicine Prague Czech Republic

Department of Cardiovascular Surgery Institute for Clinical and Experimental Medicine Prague Czech Republic

DZHK Partner Site Berlin Berlin Germany

EUROMACS Registry EACTS Windsor UK

See more in PubMed

Piacentino V 3rd, Williams ML, Depp T, Garcia-Huerta K, Blue L, Lodge AJ. et al. Impact of tricuspid valve regurgitation in patients treated with implantable left ventricular assist devices. Ann Thorac Surg 2011;91:1342–6; discussion 6–7. PubMed

Veen KM, Etnel JRG, Takkenberg J.. Tricuspid valve disease: surgical outcome In: Soliman OI, ten Cate FJ (eds). Practical Manual of Tricuspid Valve Diseases. Cham: Springer International Publishing, 2018, 305–27.

Morgan JA, Paone G, Nemeh HW, Murthy R, Williams CT, Lanfear DE. et al. Impact of continuous-flow left ventricular assist device support on right ventricular function. J Heart Lung Transplant 2013;32:398–403. PubMed

Atluri P, Fairman AS, MacArthur JW, Goldstone AB, Cohen JE, Howard JL. et al. Continuous flow left ventricular assist device implant significantly improves pulmonary hypertension, right ventricular contractility, and tricuspid valve competence. J Card Surg 2013;28:770–5. PubMed PMC

Lee S, Kamdar F, Madlon-Kay R, Boyle A, Colvin-Adams M, Pritzker M. et al. Effects of the HeartMate II continuous-flow left ventricular assist device on right ventricular function. J Heart Lung Transplant 2010;29:209–15. PubMed

de By TM, Mohacsi P, Gummert J, Bushnaq H, Krabatsch T, Gustafsson F. et al. The European Registry for Patients with Mechanical Circulatory Support (EUROMACS): first annual report. Eur J Cardiothorac Surg 2015;47:770–6; discussion 6–7. PubMed

Deo SV, Daly RC, Altarabsheh SE, Hasin T, Zhao Y, Shah IK. et al. Predictive value of the model for end-stage liver disease score in patients undergoing left ventricular assist device implantation. ASAIO J 2013;59:57–62. PubMed

Cowger J, Sundareswaran K, Rogers JG, Park SJ, Pagani FD, Bhat G. et al. Predicting survival in patients receiving continuous flow left ventricular assist devices: the HeartMate II risk score. J Am Coll Cardiol 2013;61:313–21. PubMed

Maeder MT, Holst DP, Kaye DM.. Tricuspid regurgitation contributes to renal dysfunction in patients with heart failure. J Card Fail 2008;14:824–30. PubMed

Wu Y, Takkenberg JJ, Grunkemeier GL.. Measuring follow-up completeness. Ann Thorac Surg 2008;85:1155–7. PubMed

Rizopoulos D. Joint Models for Longitudinal and Time-to-Event Data: With Applications in R. New York: Chapman and Hall/CRC, 2012.

Kirklin JK, Xie R, Cowger J, de By T, Nakatani T, Schueler S. et al. Second annual report from the ISHLT Mechanically Assisted Circulatory Support Registry. J Heart Lung Transplant 2018;37:685–91. PubMed

Song HK, Gelow JM, Mudd J, Chien C, Tibayan FA, Hollifield K. et al. Limited utility of tricuspid valve repair at the time of left ventricular assist device implantation. Ann Thorac Surg 2016;101:2168–75. PubMed PMC

Fender EA, Zack CJ, Nishimura RA.. Isolated tricuspid regurgitation: outcomes and therapeutic interventions. Heart 2018;104:798–806. PubMed PMC

Agricola E, Marini C, Stella S, Monello A, Fisicaro A, Tufaro V. et al. Effects of functional tricuspid regurgitation on renal function and long-term prognosis in patients with heart failure. J Cardiovasc Med (Hagerstown) 2017;18:60–8. PubMed

Papageorgiou G, Grant SW, Takkenberg JJM, Mokhles MM.. Statistical primer: how to deal with missing data in scientific research? Interact CardioVasc Thorac Surg 2018;27:153–8. PubMed

Anwer LA, Tchantchaleishvili V, Poddi S, Daly RC, Joyce LD, Kushwaha SS. et al. Atrial fibrillation should guide prophylactic tricuspid procedures during left ventricular assist device implantation. ASAIO J 2018;64:586–93. PubMed

Tornos Mas P, Rodriguez-Palomares JF, Antunes MJ.. Secondary tricuspid valve regurgitation: a forgotten entity. Heart 2015;101:1840–8. PubMed PMC

Fukuda S, Song JM, Gillinov AM, McCarthy PM, Daimon M, Kongsaerepong V. et al. Tricuspid valve tethering predicts residual tricuspid regurgitation after tricuspid annuloplasty. Circulation 2005;111:975–9. PubMed

Chang CC, Veen KM, Hahn RT, Bogers A, Latib A, Oei FBS. et al. Uncertainties and challenges in surgical and transcatheter tricuspid valve therapy: a state-of-the-art expert review. Eur Heart J 2020;41:1932–40. PubMed

Grant AD, Thavendiranathan P, Rodriguez LL, Kwon D, Marwick TH.. Development of a consensus algorithm to improve interobserver agreement and accuracy in the determination of tricuspid regurgitation severity. J Am Soc Echocardiogr 2014;27:277–84. PubMed